Concepedia

Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients

John W. Smith, Svetislava J. Vukelja, Amy Rabe, N. Wentworth-Hartung, Nicholas Koutrelakos, Spencer H. Shao, Thomas Whittaker, Yunfei Wang, Lina Asmar, Diane Opatt McDowell,

Breast Cancer Research and Treatment · 2013 · 13 citations · 20 references

DOI

Concepts

References

20

The National Comprehensive Cancer Network

William T. McGivney · Cancer · 1998 · 16.9K citations

, , +17

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3K citations · Full text

Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action

Suzanne B. Buck, Sam F. Victory, Richard H. Himes et al. · 1998 · 983 citations

, , +6

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840

Andrew D. Seidman, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2008 · 600 citations · Full text

Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment

E. Donnall Thomas, Henry Gómez, Rubi K. Li et al. · Journal of Clinical Oncology · 2007 · 483 citations · Full text